<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Short-Communication" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JCSR</journal-id>
      <journal-title-group>
        <journal-title>Journal of Current Scientific Research</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2766-8681</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">JCSR-21-3805</article-id>
      <article-id pub-id-type="doi">10.14302/issn.2766-8681.jcsr-21-3805</article-id>
      <article-categories>
        <subj-group>
          <subject>Short-Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A One-Pot Synthesis of Sulfonyl Amidinesvia Three-Component Reaction Under Mild and Solvent-Free Conditions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chiaa</surname>
            <given-names>Adiche</given-names>
          </name>
          <xref ref-type="aff" rid="idm1849558860">1</xref>
          <xref ref-type="aff" rid="idm1849558500">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Douniazad</surname>
            <given-names>El Abed</given-names>
          </name>
          <xref ref-type="aff" rid="idm1849558860">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1849558860">
        <label>1</label>
        <addr-line>Laboratory of Fine Chemistry (L.F.C), Chemistry Department, Faculty of Exact and Applied Sciences University of Oran 1 Ahmed BenBella BP 1524 El M’naouer Oran 31000 Algeria.</addr-line>
      </aff>
      <aff id="idm1849558500">
        <label>*</label>
        <addr-line>Corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Shailendra</surname>
            <given-names>Dwivedi</given-names>
          </name>
          <xref ref-type="aff" rid="idm1849674740">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1849674740">
        <label>1</label>
        <addr-line>University of Oklahoma | ou Â· Department of Obstetrics and Gynecology.</addr-line>
      </aff>
      <author-notes>
        <corresp>Chiaa Adiche, Laboratory of Fine Chemistry (L.F.C), Chemistry Department, Faculty of Exact and Applied Sciences, University of Oran 1 Ahmed BenBella, BP 1524 El M’naouer, Oran 31000, Algeria. Email: <email>c.adiche@yahoo.fr</email></corresp>
        <fn fn-type="conflict" id="idm1850784684">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2021-12-17">
        <day>17</day>
        <month>12</month>
        <year>2021</year>
      </pub-date>
      <volume>1</volume>
      <issue>3</issue>
      <fpage>1</fpage>
      <lpage>12</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>04</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>05</month>
          <year>2021</year>
        </date>
        <date date-type="online">
          <day>17</day>
          <month>12</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Chiaa Adiche, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org//jcsr/article/1742">This article is available from http://openaccesspub.org//jcsr/article/1742</self-uri>
      <abstract>
        <p>A convenient one-pot synthetic protocol for the preparation of sulfonyl amidines has been developed. The procedure combines three-component reaction of sulfonyl azide, methyl propiolate and secondary cyclic amine coupling in one sequence without any solvent or catalyst and at room temperature. The reaction proceeds smoothly and a variety of desired sulfonyl amidines were obtained in moderate to good yields. This protocol has synthetic advantages in terms of low environmental impact and very short reaction time.</p>
      </abstract>
      <kwd-group>
        <kwd>Multicomponent reactions</kwd>
        <kwd>sulfonylamidines</kwd>
        <kwd>terminal alkyne.</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="4"/>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1849415924" sec-type="intro">
      <title>Introduction</title>
      <p>Multicomponent reactions (MCRs) are a powerful tool for the synthesis of complex molecules with broad structural diversity in a single operation.<xref ref-type="bibr" rid="ridm1842839924">1</xref> These reactions combine at least three or more reactants in a one-pot reaction to form a new product that incorporates structural features of each reagent.<xref ref-type="bibr" rid="ridm1842836972">2</xref> Compared to conventional multistep organic syntheses, this strategy offers several other advantages besides atom economy, such as higher overall yields, shorter reaction times, environmentally benign milder reactions, and easiness of procedure.<xref ref-type="bibr" rid="ridm1842903932">3</xref>MCRs have played a central role in the development of modern synthetic methodology for biologically active compounds<italic>, </italic>bioactive heterocycles and natural products.<xref ref-type="bibr" rid="ridm1842848356">4</xref>Heterocyclic compounds constitute the largest and most varied family of organic compounds significant to almost all aspects of modern organic chemistry, medicinal chemistry, and biochemistry.<xref ref-type="bibr" rid="ridm1842913004">5</xref>Amidines,the dinitrogen analogs of carboxylic acids, are widely used in medicinal chemistry,<xref ref-type="bibr" rid="ridm1842909476">6</xref>coordination chemistry,<xref ref-type="bibr" rid="ridm1842693628">7</xref>and synthetic chemistry.<xref ref-type="bibr" rid="ridm1842692476">8</xref>They are important units in chemistry for the synthesis of various diversified nitrogen heterocycles<xref ref-type="bibr" rid="ridm1842690172">9</xref>e.g.,pyrroles,<xref ref-type="bibr" rid="ridm1842697156">10</xref>triazoles,<xref ref-type="bibr" rid="ridm1842688956">11</xref>pyridines,<xref ref-type="bibr" rid="ridm1842685356">12</xref>pyrimidines,<xref ref-type="bibr" rid="ridm1842683556">13</xref>thiadiazines<xref ref-type="bibr" rid="ridm1842676772">14</xref>and triazines.<xref ref-type="bibr" rid="ridm1842674396">15</xref>In addition, these compounds are found in numerous natural bioactive products and are identified as important pharmacophores.<xref ref-type="bibr" rid="ridm1842673100">16</xref></p>
      <p>Indeed, a broad range of nitrogen compounds containing an amidine moiety have interesting biological properties, such as anti-inflammatory, <xref ref-type="bibr" rid="ridm1842679724">17</xref>antiparasitic,<xref ref-type="bibr" rid="ridm1842665732">18</xref>antiplatelet,<xref ref-type="bibr" rid="ridm1842662420">19</xref>antimalarial,<xref ref-type="bibr" rid="ridm1842659324">20</xref>anticancer<xref ref-type="bibr" rid="ridm1842679724">17</xref>,<xref ref-type="bibr" rid="ridm1842656372">21</xref>and antimicrobial activities,<xref ref-type="bibr" rid="ridm1842656156">22</xref>etc. The sulfonyl amidine units also show broad-spectrum biological activities. In order to illustrate the importance of the sulfonyl amidine motifs in the field of pharmaceutical chemistry, a few examples of molecules with biological and therapeutic activities (antitumor,<xref ref-type="bibr" rid="ridm1842667964">23</xref>antiproliferative,<xref ref-type="bibr" rid="ridm1842647948">24</xref>antibacterial,<xref ref-type="bibr" rid="ridm1842644564">25</xref>and antiresorptive <xref ref-type="bibr" rid="ridm1842646004">26</xref>) incorporating them have been selected in <xref ref-type="fig" rid="idm1842808188">figure 1</xref>. </p>
      <fig id="idm1842808188">
        <label>Figure 1.</label>
        <caption>
          <title> Selected examples for bioactive sulfonylamidines</title>
        </caption>
        <graphic xlink:href="images/image1.png" mime-subtype="png"/>
      </fig>
      <p>There are several strategies described in the literature for the synthesis of amidines.<xref ref-type="bibr" rid="ridm1842642980">27</xref>The most common method is based on the simple functional group transformation from some precursors such as nitriles, <xref ref-type="bibr" rid="ridm1842637076">28</xref>amides.<xref ref-type="bibr" rid="ridm1842653060">29</xref> Other methods for their preparation include the reduction of amidoxime,<xref ref-type="bibr" rid="ridm1842652124">30</xref>the cycloaddition-decarboxylation of isocyanates and nitrones.<xref ref-type="bibr" rid="ridm1842629516">31</xref>Also, they were prepared by the reductive functionalization of carboxamides (<italic>via </italic>enamines) into sulfonylformamidines.<xref ref-type="bibr" rid="ridm1842627284">32</xref> Furthermore, they are prepared using the 1,3-dipolar cycloaddition reaction between the enaminoesters and sulfonyl azides,<xref ref-type="bibr" rid="ridm1842625124">33</xref> etc. Recently, numerous methods for the synthesis of sulfonyl amidines have been reported.<xref ref-type="bibr" rid="ridm1842622316">34</xref>Among various MCRs developed, the Cu-catalyzed three-component coupling reactions of a terminal alkyne, a sulfonyl azide and with a third component, like amine, alcohol or water are one of the most powerful strategies for forming sulfonyl amidines, N-sulfonylimidates, and sulfonamides, respectively.<xref ref-type="bibr" rid="ridm1842622820">35</xref>A highly efficient copper-catalyzed one-pot synthesis of <italic>N</italic>-sulfonyl amidines has been described by Chang and co-workers <italic>via </italic>the coupling of a sulfonyl azide, an alkyne and an amine.<xref ref-type="bibr" rid="ridm1842622820">35</xref>,<xref ref-type="bibr" rid="ridm1842620012">36</xref>Many other copper catalyzed three-component reaction, involving a sulfonyl azide, an alkyne and an amine, are performed under widely differing conditions have been reported by Wang’s group<xref ref-type="bibr" rid="ridm1842633548">37</xref> and others.<xref ref-type="bibr" rid="ridm1842615188">38</xref>However, these approaches to synthesize sulfonyl amidines suffered from some disadvantages including stepwise synthesis, harsh reaction conditions, long reaction times and requirement of inert atmosphere, the use of catalyst or expensive reagents and hazardous organic solvents. </p>
      <p>Therefore, the development of a mild, simple, fast and novel method with attractive features such as easily accessible starting materials, mild reaction conditions, and non-toxic side products to generate structural diversity sulfonyl amidines is still desirable because of their biological significance. As a continuation of our interest in developing new green synthetic methods of sulfonyl amidines,<xref ref-type="bibr" rid="ridm1842612740">39</xref> herein we  report a facile, rapid and  practical synthesis of sulfonyl amidines, potentially bioactive, <italic>via</italic> a MCR performed in air, coupling of arenesulfonylazides with methyl propiolate and secondary cyclic amines using solvent-free conditions and without requiring any catalyst or additive.</p>
    </sec>
    <sec id="idm1849396020">
      <title>Experimental</title>
      <p>All reagents and solvents were purchased from commercial suppliers and were used without further purification. Melting points were determined with a Kofler apparatus and they are uncorrected. 1H (300 MHz) and 13C (75 MHz), NMR spectra were recorded using a Bruker AC300 spectrometer using CDCl3.Infrared spectra (IR) were taken on a Nicolet IRFT IR 200 spectrometer, and were obtained as solids in KBr. Peaks are reported in cm-1. High-resolution mass spectra (MS) were obtained at 2.8kV electrospray voltage, 20 V voltage orifice, and flow of nebulizing gas (nitrogen): 100 L/h. </p>
      <p>Atmospheric pressure ionization (API) and electrospray (ESI) mass spectra were recorded on a SYNAPTG2 HDMS spectrometer (Waters). Elemental analyses were performed by apparatus CHNS. </p>
      <sec id="idm1849397748">
        <title>General Procedure for Preparing Sulfonyl Azides:</title>
        <p>The sulfonyl azides1 were prepared according to the procedure of the literature<xref ref-type="bibr" rid="ridm1842610436">40</xref>which was modified as follows: sulfonyl chloride (30 mmol) in acetone (25 mL) was added drop wise to a solution of sodium azide (33 mmol) in 10mL of ethanol (96%) at room temperature. Upon addition the solution turns an orange color with NaCl precipitate was seen. After stirring for 15 hours the precipitate was filtered off and the solvent was evaporated. The residue was taken up with water and extracted with 25 mL dichloromethane. The organic layer was dried over anhydrous MgSO4, filtered and the solvent was evaporated under reduced pressure to give the desired sulfonyl azide. </p>
      </sec>
      <sec id="idm1849378084">
        <title>General Procedure for Synthesis of Sulfonyl Amidines under Mild and Solvent-free Conditions: </title>
        <p>Sulfonylazide1 (1 mmol,1 equiv.), methyl propiolate (1 mmol,1 equiv.) and amine 2 (1 mmol,1 equiv.) was successively added to a flask at room temperature, after that a precipitate was formed,a pure product was obtained by recrystallization in EtOH followed by simple filtration.</p>
      </sec>
    </sec>
    <sec id="idm1849376500" sec-type="results">
      <title>Results and Discussion</title>
      <p>Sulfonyl amidines <bold>3</bold>-<bold>5</bold> are obtained by a direct three-component reaction of arenesulfonylazide, methyl propiolate with secondary cyclic amines (<xref ref-type="fig" rid="idm1842780260">Scheme 1</xref>).</p>
      <fig id="idm1842780260">
        <label>Scheme 1.</label>
        <caption>
          <title> One pot synthesis of sulfonylamidines 3-5</title>
        </caption>
        <graphic xlink:href="images/image2.jpg" mime-subtype="jpg"/>
      </fig>
      <p>The structure of synthesized sulfonyl amidines 3-5 was confirmed mainly by a combination of the usual spectroscopic methods (IR, <sup>1</sup>H, <sup>13</sup>C, DEPT NMR) elemental analysis, and the mass spectra which gave good agreement with the proposed structures.</p>
      <p>The reaction conditions for a sequential one-pot procedure were optimized using different solvents, as illustrated in <xref ref-type="table" rid="idm1842779684">Table 1</xref>.</p>
      <table-wrap id="idm1842779684">
        <label>Table 1.</label>
        <caption>
          <title> Optimization of the reaction conditions for the three-component reactions of tosylazide1a,                    methyl propiolate and morpholine2a.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>
                <inline-graphic xlink:href="images/image3.jpg" mime-subtype="jpg"/>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1849382476">
            <label/>
            <p><sup>a</sup>Reaction conditions: tosylazide<bold>1a</bold> (1 mmol, 1 equiv.), methyl propiolate (1 mmol, 1 equiv.), and                 morpholine<bold>2a </bold>(1 mmol, 1 equiv.), <sup>b</sup>Isolated  yield  after recrystallization in ethanol followed by simple filtration. </p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Preliminary experiments were carried out with tosylazide <bold>1a</bold>, methyl propiolate and morpholine <bold>2a</bold>. The reactions were performed in various solvents. As can be seen from <xref ref-type="table" rid="idm1842779684">Table 1</xref>, THF, CH<sub>2</sub>Cl<sub>2</sub>, methanol and toluene afforded low yields (<xref ref-type="table" rid="idm1842779684">Table 1</xref>, entries 1, 3, 5 and 7), where as the solvents H<sub>2</sub>O, CHCl<sub>3</sub>, and DMSO achieved moderate yield (<xref ref-type="table" rid="idm1842779684">Table 1</xref>, entries 2, 6 and 8). The reaction accomplished in ether leads to a good yield (<xref ref-type="table" rid="idm1842779684">Table 1</xref>, entry 4). However, the best yield was obtained in the absence of the solvent (<xref ref-type="table" rid="idm1842779684">Table 1</xref>, entry 9).  </p>
      <p>To extend the general applicability and the reactivity of this three-component reaction, several substituted sulfonyl azides <bold>1</bold> bearing electron-donating and electron-withdrawing groups, were reacted with methyl propiolate and secondary cyclic amines (morpholine, piperidine and pyrrolidine) under the optimized conditions in the absence of solvent and without any catalyst, the results are given in <xref ref-type="table" rid="idm1842740972">Table 2</xref>, <xref ref-type="table" rid="idm1842747668">Table 3</xref>, <xref ref-type="table" rid="idm1842721140">Table 4</xref></p>
      <p>Arenesulfonylazides were successfully employed as efficient reacting partners in three-component coupling with methyl propiolate and morpholine to afford the corresponding sulfonyl amidines (<bold>3a-l</bold>) which were produced with yields varying from 22 to 89%, spontaneously. The reactions proceeded very efficiently, and led to the formation of the corresponding sulfonyl amidines <bold>3a</bold>, <bold>3d</bold> and <bold>3e</bold> in good yields (<xref ref-type="table" rid="idm1842740972">Table 2</xref>, entries 1, 4 and 5) as 89, 84 and 88%, respectively. However, a drastic decrease in yield (32 and 29%) was observed with the benzene sulfonyl azide and the <italic>para</italic>-ethylbenzenesulfonylazide (<xref ref-type="table" rid="idm1842740972">Table 2</xref>, entries 2 and 3). On the other hand, the electron with-drawing <italic>para</italic>-nitro was found to be more reactive than the <italic>ortho</italic>-nitro and the <italic>meta</italic>-nitrobenzenesulfonylazides (<xref ref-type="table" rid="idm1842740972">Table 2</xref>, entries 5-7) with 88, 41 and 54%, respectively. The reaction was also compatible with the presence of the halogen groups. Thus, the bromo and iodo groups led to the desired products <bold>3j</bold>, and <bold>3k</bold> with better yields compared to the fluoro and chloro groups which led to the compounds <bold>3h</bold> and <bold>3i</bold> (<xref ref-type="table" rid="idm1842740972">Table 2</xref>, entries 8-11) with 72 , 64, 22 and 42%, respectively. It is noted that the disulfonylamidine<bold>3l</bold> was obtained with a yield of 66% (<xref ref-type="table" rid="idm1842740972">Table 2</xref>, entry 12).</p>
      <table-wrap id="idm1842740972">
        <label>Table 2.</label>
        <caption>
          <title> Sulfonyl amidines3 prepared from methyl propiolate, arenesulfonylazides and morpholinea</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>
                <inline-graphic xlink:href="images/image4.jpg" mime-subtype="jpg"/>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1849358148">
            <label/>
            <p><sup>a</sup>Reaction conditions: arenesulfonylazide<bold>1</bold> (1 mmol, 1 equiv.), methyl propiolate (1 mmol, 1 equiv.), and  morpholine<bold>2a </bold>(1 mmol, 1 equiv.), <sup>b</sup>Isolated yield after recrystallization in ethanol followed by simple               filtration, <sup>c</sup>Benzene-1,3-disulfonyl azide (1 mmol, 1 equiv.), methyl propiolate (2 mmol, 2 equiv.), and                morpholine<bold>2a</bold> (2 mmol, 2 equiv.). </p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In addition, the system was applied to other amines. The results obtained for the synthesis of sulfonyl amidines (<bold>4a-i</bold>) from piperidine are given in the <xref ref-type="table" rid="idm1842747668">Table 3</xref>.</p>
      <p>Using piperidine as nucleophilic partner, we evaluated the ability to perform the three-component reaction. This reaction sequence generated the corresponding sulfonyl amidines (<bold>4a-i</bold>) with yields ranging from 11 to 81%. The best yield was obtained from the <italic>para</italic>-nitro benzenesulfonylazide. Indeed, the <italic>para</italic>-nitro benzenesulfonylazide has a decisive influence on the successful formation of 4c (<xref ref-type="table" rid="idm1842747668">Table 3</xref>, entry 3) as 81%. The <italic>ortho-</italic>nitro and the <italic>meta</italic>-nitro benzenesulfonylazide were also examined as electron with-drawing source and gave the targeted products <bold>4d</bold> and <bold>4e</bold> in moderate yields (<xref ref-type="table" rid="idm1842747668">Table 3</xref>, entries 4 and 5) as 51 and 44%. The presence of either electron-donating groups (Me) or (2,4,6-triisopropyl) on benzenesulfonylazide provides almost similar yields (<xref ref-type="table" rid="idm1842747668">Table 3</xref>, entries 1 and 2) around 40%. The arenesulfonylazides containing a halogen group reacted with piperidine and methyl propiolate were unsuccessful. The corresponding products <bold>4f-h</bold> were obtained in weak yields (<xref ref-type="table" rid="idm1842779684">Table 1</xref>, entries 6-8), with 14, 13 and 11% yields, respectively.  The benzene-1,3-disulfonylazide give low yield of the desired product <bold>4i </bold>(<xref ref-type="table" rid="idm1842747668">Table 3</xref>, entry 9) with a 28% yield. </p>
      <p>Difference in reactivity was also observed when pyrrolidine was used. The results obtained for the synthesis of sulfonyl amidines (<bold>5a-j</bold>) are shown in the <xref ref-type="table" rid="idm1842721140">Table 4</xref>.</p>
      <table-wrap id="idm1842747668">
        <label>Table 3.</label>
        <caption>
          <title> Sulfonyl amidines4 prepared from methyl propiolate, arenesulfonylazides and piperidinea</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>
                <inline-graphic xlink:href="images/image5.jpg" mime-subtype="jpg"/>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1849335276">
            <label/>
            <p><sup>a</sup>Reaction conditions: arenesulfonylazide<bold>1</bold> (1 mmol, 1 equiv.), methyl propiolate (1 mmol, 1 equiv.), and  piperidine <bold>2b</bold> (1 mmol, 1 equiv.), <sup>b</sup>Isolated  yield  after recrystallization  in ethanol followed by simple filtration, <sup>c</sup>Benzene-1,3-disulfonyl azide(1 mmol, 1 equiv.), methyl propiolate (2 mmol, 2 equiv.), and  piperidine <bold>2b</bold> (2 mmol, 2 equiv.) </p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="idm1842721140">
        <label>Table 4.</label>
        <caption>
          <title> Sulfonyl amidines5 prepared from methyl propiolate, arenesulfonylazides and pyrrolidinea</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>
                <inline-graphic xlink:href="images/image6.jpg" mime-subtype="jpg"/>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1849333404">
            <label/>
            <p><sup>a</sup>Reaction conditions: arenesulfonylazide<bold>1</bold> (1 mmol, 1 equiv.), methyl propiolate (1 mmol, 1 equiv.), and  pyrrolidine <bold>2c</bold> (1 mmol, 1 equiv.), <sup>b</sup>Isolated  yield  after recrystallization  in ethanol, followed by simple filtration. <sup>c</sup>Benzene-1,3-disulfonyl azide(1 mmol, 1 equiv.), methyl propiolate (2 mmol, 2 equiv.), and pyrrolidine<bold>2c</bold> (2 mmol, 2 equiv.) </p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Next, we performed to prepare sulfonyl amidines by way of the pyrrolidine according to the same sequence and under the same conditions as the previous reactions. This reaction produces the corresponding sulfonyl amidines <bold>5a-j</bold> with yields ranging from 10 to 51%. When the reaction was run with the tosylazide and benzenesulfonylazide the sulfonyl amidines <bold>5a </bold>and <bold>5b</bold> were isolated in only 15 and 10%, respectively (<xref ref-type="table" rid="idm1842721140">Table 4</xref>, entries 1 and 2). In other hand, the 2,4,6-triisopropyl, bulky and strongly electron-withdrawing group, showed low reactivity leading to relatively moderate yield of 44% for the sulfonyl amidine <bold>5c</bold> (<xref ref-type="table" rid="idm1842721140">Table 4</xref>, entry 3). It is note that substitution of the benzenesulfonylazide by nitro group in the <italic>ortho</italic> or <italic>meta</italic> position on the phenyl ring provided the desired sulfonyl amidines <bold>5d</bold> and <bold>5e</bold> in moderate yields (<xref ref-type="table" rid="idm1842721140">Table 4</xref>, entries 4 and 5) as 43%. Also, the benzene-1,3-disulfonyl azide give the  disulfonyl amidine <bold>5i</bold> with an average yield of 51% (<xref ref-type="table" rid="idm1842721140">Table 4</xref>, entry 10). However, when the electron donor substituent has been used such as halogen groups (fluoro, chloro, bromo and iodo) low yields were obtained ranging from 22-33% in this case (<xref ref-type="table" rid="idm1842721140">Table 4</xref>, entries 6-9).</p>
      <p>On the basis of our experimental results, together studies in literature <xref ref-type="bibr" rid="ridm1842607412">41</xref>, a possible reaction mechanism for the formation of sulfonyl amidines is proposed in <xref ref-type="fig" rid="idm1842712788">Scheme 2</xref>.</p>
      <fig id="idm1842712788">
        <label>Scheme 2.</label>
        <caption>
          <title> Proposed mechanism for the synthesis of compounds 3-5.</title>
        </caption>
        <graphic xlink:href="images/image7.jpg" mime-subtype="jpg"/>
      </fig>
      <p>First the secondary cyclic amine reacts with methyl propiolate through a hydroamination reaction to afford corresponding enamine. Then, the formed enamine reacts with arenesulfonylazide to yield the unstable D<xref ref-type="bibr" rid="ridm1842836972">2</xref>1,2,3-triazolineintermediate which then release one  molecule of methyl diazoacetate to provide the expected sulfonyl amidines <bold>3</bold>-<bold>5</bold>. It should be noted that the nature of substituents of arenesulfonylazides and the cyclic secondary amine structure has a great influence on the yield of the reaction.</p>
    </sec>
    <sec id="idm1849327140" sec-type="conclusions">
      <title>Conclusion</title>
      <p>In conclusion, we have developed a fast, efficient, easy, and practical three-component reaction of arenesulfonylazides, methyl propiolate and secondary cyclic amines to produce sulfonyl amidines. The reactions were performed without any solvent or catalyst, at room temperature, very short reaction time and with moderate to good yields. Compared to previously other reported synthesis of sulfonyl amidines, this protocol is highlighted by its simplicity, atom economical nature and green operational method. </p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors cordially thank Professor J.-M Pons (Institut des Sciences Moléculaires de Marseille (ism2) of Aix-Marseille University, Faculty of Sciences) for centesimal analysis and the mass spectra.</p>
    </ack>
    <ref-list>
      <ref id="ridm1842839924">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M-X</given-names>
          </name>
          <date>
            <year>2014</year>
          </date>
          <chapter-title>Eds.Multicomponent Reactions in Organic Synthesis;Wiley-VCH Verlag GmbH:</chapter-title>
          <publisher-loc>Weinheim, Germany</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1842836972">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bienaymé</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Multicoponent reactions”, eds, Wiley-VCH</article-title>
          <date>
            <year>2005</year>
          </date>
          <publisher-loc>Weinhein Germany</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1842903932">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Andrade</surname><given-names>CKZ</given-names></name><name><surname>Dar</surname><given-names>A R</given-names></name><date><year>2016</year></date>
Tetrahedron.72: 7375


</mixed-citation>
      </ref>
      <ref id="ridm1842848356">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Ameta</surname>
            <given-names>K L</given-names>
          </name>
          <name>
            <surname>Dandia</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Multicomponent Reactions: Synthesis of Bioactive Heterocycles</article-title>
          <date>
            <year>2017</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1842913004">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Mishra</surname>
            <given-names>B B</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mishra</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mohapatra</surname>
            <given-names>P P</given-names>
          </name>
          <name>
            <surname>Tiwari</surname>
            <given-names>V K</given-names>
          </name>
          <date>
            <year>2012</year>
          </date>
          <chapter-title>Advances in Heterocyclic Chemistry.107: 4</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1842909476">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>J</surname><given-names>V Greenhill</given-names></name><name><surname>Lue</surname><given-names>P</given-names></name><name><surname>Prog</surname><given-names/></name>

Med. Chem.30(1993)203;


</mixed-citation>
      </ref>
      <ref id="ridm1842693628">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Barker</surname><given-names>J</given-names></name><name><surname>Kilner</surname><given-names>M</given-names></name><name><surname>Coord</surname><given-names/></name>

Chem. Rev.133(1994)219;


</mixed-citation>
      </ref>
      <ref id="ridm1842692476">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Boyd</surname>
            <given-names>G V</given-names>
          </name>
          <article-title>Reactions and synthetic uses of amidines”In The Chemistry of Amidines</article-title>
          <date>
            <year>1991</year>
          </date>
          <fpage>367</fpage>
          <publisher-name>John Wiley &amp; Sons</publisher-name>
          <publisher-loc>New York,2:</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1842690172">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Aly</surname><given-names>A A</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Nour-El-Din</surname><given-names>A M</given-names></name><date><year>2008</year></date>
Arkivoc.153


</mixed-citation>
      </ref>
      <ref id="ridm1842697156">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Ito</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kizuka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ihara</surname>
            <given-names>S</given-names>
          </name>
          <date>
            <year>2006</year>
          </date>
          <chapter-title>Heterocyclic Chem.43:</chapter-title>
          <fpage>1217</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842688956">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Sudheendran</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Schmidt</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Frey</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Conrad</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Beifus</surname>
            <given-names>U</given-names>
          </name>
          <date>
            <year>2014</year>
          </date>
          <source>Tetrahedron</source>
          <volume>70</volume>
          <fpage>1635</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842685356">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Guo</surname>
            <given-names>W</given-names>
          </name>
          <date>
            <year>2016</year>
          </date>
          <source>Chinese Chem. Lett</source>
          <volume>27</volume>
          <fpage>47</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842683556">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bellur</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Langer</surname>
            <given-names>P</given-names>
          </name>
          <date>
            <year>2006</year>
          </date>
          <source>Tetrahedron</source>
          <volume>62</volume>
          <fpage>5426</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842676772">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Hajri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Abderrahim</surname>
            <given-names>R</given-names>
          </name>
          <date>
            <year>2011</year>
          </date>
          <source>Phosphorus, Sulfur, Silicon, Relat. Elem.186:</source>
          <fpage>520</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842674396">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <date>
            <year>2020</year>
          </date>
          <source>Eur. J. Org. Chem.21:</source>
          <fpage>860</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842673100">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="book"><name><surname>Kumamoto</surname><given-names>T</given-names></name><date><year>2009</year></date><chapter-title>Amidines and Guanidines in Natural Products and Medicines” In “Superbases for OrganicSynthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysts”</chapter-title><fpage>295</fpage>
ed. by I. Ishikawa
<publisher-name>John Wiley &amp; Sons Press</publisher-name><publisher-loc>West Sussex, UK</publisher-loc></mixed-citation>
      </ref>
      <ref id="ridm1842679724">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Sondhi</surname><given-names>S M</given-names></name><name><surname>Dinodia</surname><given-names>M</given-names></name><article-title>A Kumar</article-title>
(2006).Bioorg. Med. Chem.14: 4657


</mixed-citation>
      </ref>
      <ref id="ridm1842665732">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>FE</surname>
            <given-names>Goda Barghash</given-names>
          </name>
          <name>
            <surname>Eisa</surname>
            <given-names>H M</given-names>
          </name>
          <name>
            <surname>Wenzler</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brun</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mickelson</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>W D</given-names>
          </name>
          <name>
            <surname>Boykin</surname>
            <given-names>D W</given-names>
          </name>
          <date>
            <year>2010</year>
          </date>
          <source>Bioorg. Med. Chem.18:</source>
          <fpage>557</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842662420">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Sielecki</surname>
            <given-names>T M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mousa</surname>
            <given-names>S A</given-names>
          </name>
          <name>
            <surname>Racanelli</surname>
            <given-names>A L</given-names>
          </name>
          <name>
            <surname>Hausner</surname>
            <given-names>E A</given-names>
          </name>
          <chapter-title>RR Wexler and RE Olson. (2001).Bioorg.Med. Chem. Lett.11:</chapter-title>
          <fpage>2202</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842659324">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Calas</surname><given-names>M</given-names></name><name><surname>Ouattara</surname><given-names>M</given-names></name><name><surname>Piquert</surname><given-names>G</given-names></name><name><surname>Ziora</surname><given-names>Z</given-names></name><name><surname>Bordat</surname><given-names>Y</given-names></name><name><surname>Ancelin</surname><given-names>M L</given-names></name><name><surname>Escale</surname><given-names>R</given-names></name><name><surname>Vial</surname><given-names>H</given-names></name>

(2007).J Med. Chem.50: 6307


</mixed-citation>
      </ref>
      <ref id="ridm1842656372">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Racane</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kralj</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Šuman</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Stojkovic</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tralic-Kulenovic</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Karminski</surname>
            <given-names>G</given-names>
          </name>
          <date>
            <year>2010</year>
          </date>
          <source>Bioorg. Med</source>
          <volume>18</volume>
          <fpage>1038</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842656156">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Turan</surname><given-names>Z G</given-names></name><name><surname>Sivaci</surname><given-names>D M</given-names></name><name><surname>Kaplancikli</surname><given-names>Z A</given-names></name><article-title>A Ozdemir</article-title>
(2002).Il Farmaco,57(2002) 569;


</mixed-citation>
      </ref>
      <ref id="ridm1842667964">
        <label>23.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Song</surname><given-names>Z L</given-names></name><name><surname>Chen</surname><given-names>H L</given-names></name><name><surname>Y</surname><given-names>H Wang</given-names></name><name><surname>Goto</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>W J</given-names></name><name><surname>Cheng</surname><given-names>P L</given-names></name><name><surname>Morris-Natschke</surname><given-names>S L</given-names></name><name><surname>Liu</surname><given-names>Y Q</given-names></name><name><surname>Zhu</surname><given-names>G X</given-names></name><name><surname>Wang</surname><given-names>M J</given-names></name><name><surname>Lee</surname><given-names>K H</given-names></name>

(2015).Bioorg. Med.Chem. Lett.25: 2690


</mixed-citation>
      </ref>
      <ref id="ridm1842647948">
        <label>24.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Krstulović</surname><given-names>L</given-names></name><name><surname>Saftić</surname><given-names>D</given-names></name><name><surname>Ismaili</surname><given-names>H</given-names></name><name><surname>Bajić</surname><given-names>M</given-names></name><name><surname>Glavaš-Obrovac</surname><given-names>L</given-names></name><name><surname>Žinić</surname><given-names>B</given-names></name>

(2017).Croat. Chem. Acta,90: 625


</mixed-citation>
      </ref>
      <ref id="ridm1842644564">
        <label>25.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>L</surname>
            <given-names>P Graham</given-names>
          </name>
          <name>
            <surname>D</surname>
            <given-names>P Patrick</given-names>
          </name>
          <name>
            <surname>ChimiePharmaceutique</surname>
            <given-names/>
          </name>
          <date>
            <year>2003</year>
          </date>
          <publisher-loc>Paris, de Boeck, 355</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1842646004">
        <label>26.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>S</surname>
            <given-names>Chang Baek</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S H</given-names>
          </name>
          <date>
            <year>2011</year>
          </date>
          <source>Bioorg. Med. Chem. Lett.21:</source>
          <fpage>727</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842642980">
        <label>27.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Dekorver</surname>
            <given-names>K A</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>W L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hsung</surname>
            <given-names>R P</given-names>
          </name>
          <name>
            <surname>J</surname>
            <given-names>Deng HDai</given-names>
          </name>
          <name>
            <surname>Lohse</surname>
            <given-names>A G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y S</given-names>
          </name>
          <date>
            <year>2011</year>
          </date>
          <volume>76</volume>
          <fpage>5092</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842637076">
        <label>28.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Volkova</surname>
            <given-names>K A</given-names>
          </name>
          <name>
            <surname>Albanov</surname>
            <given-names>A I</given-names>
          </name>
          <date>
            <year>2006</year>
          </date>
          <source>Russ. J. Org. Chem.42:</source>
          <fpage>1730</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842653060">
        <label>29.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Das</surname>
            <given-names>V K</given-names>
          </name>
          <name>
            <surname>Thakur</surname>
            <given-names>A J</given-names>
          </name>
          <date>
            <year>2013</year>
          </date>
          <chapter-title>Tetrahedron Lett.54:</chapter-title>
          <fpage>4164</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842652124">
        <label>30.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>H J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>W H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z L</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Z</given-names>
          </name>
          <date>
            <year>2002</year>
          </date>
          <source>Chinese Chem.Lett</source>
          <volume>13</volume>
          <fpage>3</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842629516">
        <label>31.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>M M</given-names>
          </name>
          <date>
            <year>2020</year>
          </date>
          <chapter-title>Synthesis.52:</chapter-title>
          <fpage>1773</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842627284">
        <label>32.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Trillo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Slagbrand</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tinnis</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Adolfsson</surname>
            <given-names>H</given-names>
          </name>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Chemistry Open.6:</chapter-title>
          <fpage>484</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842625124">
        <label>33.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Wan</surname>
            <given-names>X Zhengand JP</given-names>
          </name>
          <date>
            <year>2019</year>
          </date>
          <source>Adv. Synth. Catal</source>
          <volume>361</volume>
          <fpage>5690</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842622316">
        <label>34.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Chin</surname>
            <given-names/>
          </name>
          <source>J. Org. Chem</source>
          <volume>40</volume>
          <issue>2020</issue>
          <fpage>1891</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842622820">
        <label>35.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bae</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>S</given-names>
          </name>
          <date>
            <year>2005</year>
          </date>
          <source>J Am Chem Soc. 127: 2038</source>
        </mixed-citation>
      </ref>
      <ref id="ridm1842620012">
        <label>36.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Kim</surname>
            <given-names>J Y</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S H</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>S</given-names>
          </name>
          <date>
            <year>2008</year>
          </date>
          <chapter-title>Tetrahedron Lett.49:</chapter-title>
          <fpage>1745</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842633548">
        <label>37.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Cui</surname>
            <given-names>S L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y G</given-names>
          </name>
          <date>
            <year>2007</year>
          </date>
          <chapter-title>Org. Lett.9:</chapter-title>
          <fpage>5023</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842615188">
        <label>38.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Whiting</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fokin</surname>
            <given-names/>
          </name>
          <date>
            <year>2006</year>
          </date>
          <source>Chem. Int. Ed</source>
          <volume>45</volume>
          <fpage>3157</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842612740">
        <label>39.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Adiche</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hamadouche</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D</surname>
            <given-names>El Abed</given-names>
          </name>
          <date>
            <year>2016</year>
          </date>
          <source>Heterocycles</source>
          <volume>92</volume>
          <fpage>1614</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842610436">
        <label>40.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Ruppel</surname>
            <given-names>J V</given-names>
          </name>
          <name>
            <surname>Kamble</surname>
            <given-names>R M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X P</given-names>
          </name>
          <date>
            <year>2007</year>
          </date>
          <source>Lett</source>
          <volume>9</volume>
          <fpage>4889</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842607412">
        <label>41.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>S</surname>
            <given-names>Torabi BKaboudin</given-names>
          </name>
          <name>
            <surname>Kazemi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Aoyama</surname>
            <given-names>H</given-names>
          </name>
          <date>
            <year>2020</year>
          </date>
          <chapter-title>Adv.10:</chapter-title>
          <fpage>26701</fpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
